BMI

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 223.54 M238.99 M236.98 M222.27 M203.41 M 901.66 M Gross profit 95.44 M97.81 M95.84 M92.99 M84.33 M 370.96 M Operating expenses 46.01 M52.95 M49.75 M64.64 M49.16 M 216.49 M Selling/general/admin expenses 46.01 M52.95 M49.75 M49.94 M49.16 M 201.79 M Research & development ————— — Operating income 49.42 M44.86 M46.08 M43.05 M35.17 M 169.17 M Non-Operating Income, Total ————— — Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income 50.79 M45.79 M47.44 M44.64 M36.34 M 174.21 M Equity in earnings ————— — Taxes 12.39 M11.2 M12.37 M11.07 M9 M 43.64 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 38.4 M34.58 M35.08 M33.58 M27.34 M 130.57 M Discontinued operations ————— — Net income 38.4 M34.58 M35.08 M33.58 M27.34 M 130.57 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 38.4 M34.58 M35.08 M33.58 M27.34 M 130.57 M Basic earnings per share (Basic EPS) 1.311.181.191.140.94 4.45 Diluted earnings per share (Diluted EPS) 1.31.171.191.140.93 4.43 Average basic shares outstanding 29.38 M29.41 M29.42 M29.4 M29.21 M — Diluted shares outstanding 29.56 M29.59 M29.58 M29.57 M29.37 M — EBITDA 59.04 M54.55 M56.12 M38.71 M45.36 M 194.75 M EBIT 50.76 M45.76 M47.41 M29.91 M36.31 M 159.4 M Cost of revenue 126.77 M140.28 M139.81 M127.72 M117.95 M 525.77 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 8.28 M8.79 M8.71 M8.8 M9.05 M 35.36 M